Clinical trial
Studies of White Blood Cells Derived From HHT Patients
NCT00230633 · Imperial College London, Other · Active, not recruiting
Key facts
| NCT number | NCT00230633 |
|---|---|
| Title | Studies of White Blood Cells Derived From HHT Patients |
| Official title | Studies of White Blood Cells Derived From HHT Patients |
| Lead sponsor | Imperial College London, Other |
| Collaborators | British Heart Foundation |
| Status | Active, not recruiting |
| Study type | Observational |
| Conditions | Telangiectasia, Hereditary Hemorrhagic |
| Enrollment | 200 |
| Start date | Apr 1, 2002 |
| Primary completion | Oct 1, 2026 |
| Completion | Oct 1, 2026 |
| First posted | Oct 3, 2005 |
| Last update posted | Sep 28, 2023 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: